廈門慧嘉生物科技有限公司作者
CSB-E04740h人腫瘤壞死因子α(TNF-α)ELISA試劑盒說(shuō)明書
資料類型 | doc文件 | 資料大小 | 20620 |
下載次數(shù) | 89 | 資料圖片 | 【點(diǎn)擊查看】 |
上 傳 人 | 廈門慧嘉生物科技有限公司 | 需要積分 | 0 |
關(guān) 鍵 詞 | 人腫瘤壞死因子α,TNF-α ELISA試劑盒,TNF-α,ELISA試劑盒 |
- 【資料簡(jiǎn)介】
- Human Tumor Necrosis Factor α (TNF-α) ELISA KitCatalog No. CSB-E04740h(96 T)? This immunoassay kit allows for the in vitro quantitative determination of human TNF-α concentrations in serum, plasma and other biological fluids.? Expiration date six months from the date of manufacture? FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES.廈門慧嘉生物經(jīng)營(yíng)ELISA試劑盒及抗體、細(xì)胞因子、生化試劑、耗材等生物試劑產(chǎn)品。誠(chéng)信經(jīng)營(yíng),價(jià)格實(shí)惠,服務(wù)周到,質(zhì)量有保證。歡迎廣告老師來(lái)詢!: : /download(說(shuō)明書下載)1INTRODUCTIONThe prototype ligand of the TNF superfamily, TNF-α/TNFSF1A, is a pleiotropic cytokine that plays a central role in inflammation and apoptosis. It is synthesized as a 26 kDa, type II transmembrane protein that is 233 amino acids in length. It contains a 30 amino acid (aa) cytoplasmic domain, a 26 aa transmembrane segment, and a 177 aa extracellular region. TNF-αis assembled intracellularly to form a transmembrane, non-covalently-linked homotrimeric protein. The 157 aa residue soluble form of TNF-α (sTNF-αis released from the C-terminus of the transmembrane protein through the activity of TNF-α-converting enzyme (TACE), a membrane -bound disintegrin metalloproteinase. Human cells known to express TNF-αinclude B cells, colonic columnar epithelial cells, NK and CD3+CD56+ hepatic natural T cells, macrophages, monocytes and monocyte-derived dendritic cells, CD4+ and CD8+ T cells, mast cells, neutrophils, keratinocytes, plasma cells, and adipocytes.PRINCIPLE OF THE ASSAYThe microtiter plate provided in this kit has been pre-coated with2
2024世環(huán)會(huì)【工業(yè)節(jié)能與環(huán)保展】

div6月3日,2024世環(huán)會(huì)【工業(yè)節(jié)能與環(huán)保展】于上海丨國(guó)家會(huì)展中[詳細(xì)]
- 凡本網(wǎng)注明"來(lái)源:環(huán)保在線"的所有作品,版權(quán)均屬于環(huán)保在線,轉(zhuǎn)載請(qǐng)必須注明環(huán)保在線,http://www.niunang.cn。違反者本網(wǎng)將追究相關(guān)法律責(zé)任。
- 企業(yè)發(fā)布的公司新聞、技術(shù)文章、資料下載等內(nèi)容,如涉及侵權(quán)、違規(guī)遭投訴的,一律由發(fā)布企業(yè)自行承擔(dān)責(zé)任,本網(wǎng)有權(quán)刪除內(nèi)容并追溯責(zé)任。
- 本網(wǎng)轉(zhuǎn)載并注明自其它來(lái)源的作品,目的在于傳遞更多信息,并不代表本網(wǎng)贊同其觀點(diǎn)或證實(shí)其內(nèi)容的真實(shí)性,不承擔(dān)此類作品侵權(quán)行為的直接責(zé)任及連帶責(zé)任。其他媒體、網(wǎng)站或個(gè)人從本網(wǎng)轉(zhuǎn)載時(shí),必須保留本網(wǎng)注明的作品來(lái)源,并自負(fù)版權(quán)等法律責(zé)任。
- 如涉及作品內(nèi)容、版權(quán)等問(wèn)題,請(qǐng)?jiān)谧髌钒l(fā)表之日起一周內(nèi)與本網(wǎng)聯(lián)系,否則視為放棄相關(guān)權(quán)利。